Press releases

Release
05.10.2018

Strengthening of the liquidity contract (in French)

Download
Release
03.10.2018

VALEDIA®: Key data supporting the submission of a health claim

Download
Release
02.10.2018

Successful capital increase by private placement of € 2.3M (in French)

Download
Release
01.10.2018

Launching a capital increase by private investment (in French)

Download
Release
18.09.2018

VALBIOTIS expands its innovation capacity with its Preclinical Research platform

Download
Release
11.09.2018

Positive results from Phase I/II clinical study on LpD64

Download
Release
30.08.2018

Appointment of Pascal SIRVENT to the Board of Directors of VALBIOTIS

Download
Release
17.07.2018

Half-year report of the liquidity contract – July 2018 (in French)

Download
Release
10.07.2018

Positive results from first Phase I/II clinical study of VAL-070 in hypercholesterolemia

Download